查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417685

人造血管市场报告：2030 年趋势、预测与竞争分析

Artificial Blood Vessels Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

人造血管趋势与预测

2024年至2030年，全球人造血管市场预计将以5.5%的CAGR增长。该市场的主要驱动力是血管疾病和疾病发生频率的增加、心血管手术方法的改进以及使用量的增加的假体血管。全球人造血管市场前景广阔，主动脉疾病、週边动脉疾病和血液透析市场充满机会。

人造血管按细分市场

该研究包括按聚合物、应用、最终用途和地区对全球人造血管的预测。

人造血管市场洞察

Lucintel 预测，聚对苯二甲酸乙二醇酯在预测期内仍将是最大的细分市场，因为它作为血管移植的典型生物材料被用于众多治疗应用。

由于人造血管的使用不断增加和强大的医疗基础设施，北美在预测期内仍将是最大的地区。

常问问题

Q1. 市场の成长予测は:

A1。预计2024年至2030年全球人造血管市场将以5.5%的复合CAGR成长。

Q2. 市场の成长に影响を与える主な促进要因は:

A2。这个市场的主要驱动力是血管疾病和疾病发生频率的增加、心血管手术方法的改进以及人工血管使用的增加。

Q3. 市场の主要セグメントは:

A3。全球人造血管市场前景广阔，主动脉疾病、週边动脉疾病和血液透析市场充满机会。

Q4. 市场の主要企业は:

A4。一些主要的人造血管公司如下。

  • Braun Melsungen
  • Becton, Dickinson And Company
  • Cook Medical
  • Humacyte
  • Jotec
  • Lemaitre Vascular
  • Medtronic
  • Techshot
  • Terumo Medical
  • WL Gore And Associates

Q5. 今后、最大となる市场セグメントは:

A5。 Lucintel 预测，聚对苯二甲酸乙二醇酯在预测期内仍将是最大的细分市场，因为它作为血管移植的典型生物材料被用于众多治疗应用。

Q6. 市场において、今后5年间に最大になると予想される地域は:

A6。由于人造血管的使用不断增加和强大的医疗基础设施，北美在预测期内仍将是最大的地区。

Q7. レポートのカスタマイズは可能か:

A7。是的，Lucintel 提供 10% 的客製化服务，无需任何额外费用。

目录

第 1 章：执行摘要

第 2 章：全球人造血管市场：市场动态

  • 简介、背景和分类
  • 供应链
  • 产业驱动因素与挑战

第 3 章：2018 年至 2030 年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球人造血管市场趋势（2018-2023）与预测（2024-2030）
  • 按聚合物分類的全球人造血管市场
    • 聚二噁烷酮
    • 弹性体
    • 聚对苯二甲酸乙二酯
    • 其他的
  • 全球人造血管市场（按应用）
    • 主动脉疾病
    • 週边动脉疾病
    • 血液透析
    • 其他的
    • 医院
    • 心导管实验室
    • 门诊手术中心
    • 专科诊所
    • 其他的

第 4 章：2018 年至 2030 年按地区分類的市场趋势与预测分析

  • 按地区分類的全球人造血管市场
  • 北美洲人造血管市场
    • 北美人造血管市场（依应用）：主动脉疾病、週边动脉疾病、血液透析等
  • 欧洲人造血管市场
    • 依聚合物分類的欧洲人造血管市场：聚二氧环己酮、弹性体、聚对苯二甲酸乙二酯等
    • 欧洲人造血管市场（依应用）：主动脉疾病、週边动脉疾病、血液透析等
  • 亚太地区人造血管市场
    • 依聚合物分類的亚太地区人造血管市场：聚二氧环己酮、弹性体、聚对苯二甲酸乙二酯等
    • 亚太地区人造血管市场（依应用）：主动脉疾病、週边动脉疾病、血液透析等
  • ROW人工血管市场
    • ROW人造血管市场依聚合物分类：聚二氧环己酮、弹性体、聚对苯二甲酸乙二酯等
    • ROW人造血管市场（依应用）：主动脉疾病、週边动脉疾病、血液透析等

第 5 章：竞争对手分析

  • 产品组合分析
  • 营运整合
  • 波特五力分析

第 6 章：成长机会与策略分析

  • 成长机会分析
    • 聚合物全球人造血管市场的成长机会
    • 全球人造血管市场的成长机会（按应用）
    • 按最终用途分類的全球人造血管市场的成长机会
    • 按地区分類的全球人造血管市场的成长机会
  • 全球人造血管市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球人造血管市场容量扩张
    • 全球人造血管市场的合併、收购和合资企业
    • 认证和许可

第 7 章：领先企业的公司简介

  • Braun Melsungen
  • Becton, Dickinson and Company
  • Cook Medical
  • Humacyte
  • Jotec
  • LeMaitre Vascular
  • Medtronic
  • Techshot
  • Terumo Medical
  • W. L. Gore and Associates
简介目录

Artificial Blood Vessels Trends and Forecast

The future of the global artificial blood vessels market looks promising with opportunities in the aortic disease, peripheral artery disease, and hemodialysis markets. The global artificial blood vessels market is expected to grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are increasing frequency of vascular disorders and illnesses, improvements in the methods of cardiovascular surgery, as well as, increasing use of prosthetic blood vessels.

A more than 150-page report is developed to help in your business decisions.

Artificial Blood Vessels by Segment

The study includes a forecast for the global artificial blood vessels by polymer, application, end use, and region.

Artificial Blood Vessels Market by Polymer [Shipment Analysis by Value from 2018 to 2030]:

  • Polydioxanone
  • Elastomer
  • Polyethylene Terephthalate
  • Others

Artificial Blood Vessels Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Aortic Disease
  • Peripheral Artery Disease
  • Hemodialysis
  • Others

Artificial Blood Vessels Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Cardiac Catheterization Laboratories
  • Ambulatory Surgical Centers
  • Specialty Clinics

Artificial Blood Vessels Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Artificial Blood Vessels Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies artificial blood vessels companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the artificial blood vessels companies profiled in this report include-

  • Braun Melsungen
  • Becton, Dickinson And Company
  • Cook Medical
  • Humacyte
  • Jotec
  • Lemaitre Vascular
  • Medtronic
  • Techshot
  • Terumo Medical
  • W. L. Gore And Associates

Artificial Blood Vessels Market Insights

Lucintel forecasts that polyethylene terephthalate will remain the largest segment over the forecast period because it is utilized in numerous therapeutic applications as a typical biomaterial for vascular grafts.

North America will remain the largest region over the forecast period due to the region's growing use of artificial blood vessels and strong healthcare infrastructure.

Features of the Global Artificial Blood Vessels Market

Market Size Estimates: Artificial blood vessels market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Artificial blood vessels market size by polymer, application, end use, and region in terms of value ($B).

Regional Analysis: Artificial blood vessels market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different polymer, application, end use, and regions for the artificial blood vessels market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the artificial blood vessels market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for artificial blood vessels market?

Answer: The global artificial blood vessels market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the artificial blood vessels market?

Answer: The major drivers for this market are increasing frequency of vascular disorders and illnesses, improvements in the methods of cardiovascular surgery, as well as, increasing use of prosthetic blood vessels.

Q3. What are the major segments for artificial blood vessels market?

Answer: The future of the global artificial blood vessels market looks promising with opportunities in the aortic disease, peripheral artery disease, and hemodialysis markets.

Q4. Who are the key artificial blood vessels market companies?

Answer: Some of the key artificial blood vessels companies are as follows.

  • Braun Melsungen
  • Becton, Dickinson And Company
  • Cook Medical
  • Humacyte
  • Jotec
  • Lemaitre Vascular
  • Medtronic
  • Techshot
  • Terumo Medical
  • W. L. Gore And Associates

Q5. Which artificial blood vessels market segment will be the largest in future?

Answer: Lucintel forecasts that polyethylene terephthalate will remain the largest segment over the forecast period because it is utilized in numerous therapeutic applications as a typical biomaterial for vascular grafts.

Q6. In artificial blood vessels market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the region's growing use of artificial blood vessels and strong healthcare infrastructure.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the artificial blood vessels market by polymer (polydioxanone, elastomer, polyethylene terephthalate, and others), application (aortic disease, peripheral artery disease, hemodialysis, and others), end use (hospitals, cardiac catheterization laboratories, ambulatory surgical centers, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Artificial Blood Vessels Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Artificial Blood Vessels Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Artificial Blood Vessels Market by Polymer
    • 3.3.1: Polydioxanone
    • 3.3.2: Elastomer
    • 3.3.3: Polyethylene Terephthalate
    • 3.3.4: others
  • 3.4: Global Artificial Blood Vessels Market by Application
    • 3.4.1: Aortic Disease
    • 3.4.2: Peripheral Artery Disease
    • 3.4.3: Hemodialysis
    • 3.4.4: Others
    • 3.5.1: Hospitals
    • 3.5.2: Cardiac Catheterization Laboratories
    • 3.5.3: Ambulatory Surgical Centers
    • 3.5.4: Specialty Clinics
    • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Artificial Blood Vessels Market by Region
  • 4.2: North American Artificial Blood Vessels Market
    • 4.2.2: North American Artificial Blood Vessels Market by Application: Aortic Disease, Peripheral Artery Disease, Hemodialysis, and Others
  • 4.3: European Artificial Blood Vessels Market
    • 4.3.1: European Artificial Blood Vessels Market by Polymer: Polydioxanone, Elastomer, Polyethylene Terephthalate, and others
    • 4.3.2: European Artificial Blood Vessels Market by Application: Aortic Disease, Peripheral Artery Disease, Hemodialysis, and Others
  • 4.4: APAC Artificial Blood Vessels Market
    • 4.4.1: APAC Artificial Blood Vessels Market by Polymer: Polydioxanone, Elastomer, Polyethylene Terephthalate, and others
    • 4.4.2: APAC Artificial Blood Vessels Market by Application: Aortic Disease, Peripheral Artery Disease, Hemodialysis, and Others
  • 4.5: ROW Artificial Blood Vessels Market
    • 4.5.1: ROW Artificial Blood Vessels Market by Polymer: Polydioxanone, Elastomer, Polyethylene Terephthalate, and others
    • 4.5.2: ROW Artificial Blood Vessels Market by Application: Aortic Disease, Peripheral Artery Disease, Hemodialysis, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Artificial Blood Vessels Market by Polymer
    • 6.1.2: Growth Opportunities for the Global Artificial Blood Vessels Market by Application
    • 6.1.3: Growth Opportunities for the Global Artificial Blood Vessels Market by End Use
    • 6.1.4: Growth Opportunities for the Global Artificial Blood Vessels Market by Region
  • 6.2: Emerging Trends in the Global Artificial Blood Vessels Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Artificial Blood Vessels Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Artificial Blood Vessels Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Braun Melsungen
  • 7.2: Becton, Dickinson and Company
  • 7.3: Cook Medical
  • 7.4: Humacyte
  • 7.5: Jotec
  • 7.6: LeMaitre Vascular
  • 7.7: Medtronic
  • 7.8: Techshot
  • 7.9: Terumo Medical
  • 7.10: W. L. Gore and Associates